$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 17 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.72 | 200 | 6,344 | 29,615 | 29.8 K to 29.6 K (-0.67 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.71 | 700 | 22,197 | 29,815 | 30.5 K to 29.8 K (-2.29 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.70 | 600 | 19,020 | 30,515 | 31.1 K to 30.5 K (-1.93 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.69 | 300 | 9,507 | 31,115 | 31.4 K to 31.1 K (-0.95 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.67 | 700 | 22,169 | 31,415 | 32.1 K to 31.4 K (-2.18 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.65 | 312 | 9,875 | 32,115 | 32.4 K to 32.1 K (-0.96 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.64 | 100 | 3,164 | 32,427 | 32.5 K to 32.4 K (-0.31 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.62 | 88 | 2,783 | 32,527 | 32.6 K to 32.5 K (-0.27 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.61 | 300 | 9,483 | 32,615 | 32.9 K to 32.6 K (-0.91 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.60 | 300 | 9,480 | 32,915 | 33.2 K to 32.9 K (-0.90 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.59 | 600 | 18,954 | 33,215 | 33.8 K to 33.2 K (-1.77 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.57 | 100 | 3,157 | 33,815 | 33.9 K to 33.8 K (-0.29 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.54 | 100 | 3,154 | 33,915 | 34 K to 33.9 K (-0.29 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.52 | 1,200 | 37,824 | 34,015 | 35.2 K to 34 K (-3.41 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.50 | 200 | 6,300 | 35,215 | 35.4 K to 35.2 K (-0.56 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.50 | 100 | 3,150 | 35,415 | 35.5 K to 35.4 K (-0.28 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.47 | 1,000 | 31,470 | 35,515 | 36.5 K to 35.5 K (-2.74 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.46 | 100 | 3,146 | 36,515 | 36.6 K to 36.5 K (-0.27 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.45 | 600 | 18,870 | 36,615 | 37.2 K to 36.6 K (-1.61 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.44 | 500 | 15,720 | 37,215 | 37.7 K to 37.2 K (-1.33 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.43 | 200 | 6,286 | 37,715 | 37.9 K to 37.7 K (-0.53 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.42 | 300 | 9,426 | 37,915 | 38.2 K to 37.9 K (-0.79 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.41 | 100 | 3,141 | 38,215 | 38.3 K to 38.2 K (-0.26 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.40 | 211 | 6,625 | 38,315 | 38.5 K to 38.3 K (-0.55 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.39 | 289 | 9,072 | 38,526 | 38.8 K to 38.5 K (-0.74 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.38 | 600 | 18,828 | 38,815 | 39.4 K to 38.8 K (-1.52 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.36 | 100 | 3,136 | 39,415 | 39.5 K to 39.4 K (-0.25 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.35 | 100 | 3,135 | 39,515 | 39.6 K to 39.5 K (-0.25 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.30 | 100 | 3,130 | 39,615 | 39.7 K to 39.6 K (-0.25 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.29 | 100 | 3,129 | 39,715 | 39.8 K to 39.7 K (-0.25 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.26 | 100 | 3,126 | 39,815 | 39.9 K to 39.8 K (-0.25 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.25 | 100 | 3,125 | 39,915 | 40 K to 39.9 K (-0.25 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.16 | 200 | 6,232 | 40,015 | 40.2 K to 40 K (-0.50 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.15 | 13 | 405 | 40,215 | 40.2 K to 40.2 K (-0.03 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.14 | 187 | 5,823 | 40,228 | 40.4 K to 40.2 K (-0.46 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.13 | 400 | 12,452 | 40,415 | 40.8 K to 40.4 K (-0.98 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.12 | 300 | 9,336 | 40,815 | 41.1 K to 40.8 K (-0.73 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.11 | 300 | 9,333 | 41,115 | 41.4 K to 41.1 K (-0.72 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.09 | 100 | 3,109 | 41,415 | 41.5 K to 41.4 K (-0.24 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.08 | 100 | 3,108 | 41,515 | 41.6 K to 41.5 K (-0.24 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.05 | 500 | 15,525 | 41,615 | 42.1 K to 41.6 K (-1.19 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.04 | 100 | 3,104 | 42,115 | 42.2 K to 42.1 K (-0.24 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.03 | 100 | 3,103 | 42,215 | 42.3 K to 42.2 K (-0.24 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.02 | 100 | 3,102 | 42,315 | 42.4 K to 42.3 K (-0.24 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.01 | 100 | 3,101 | 42,415 | 42.5 K to 42.4 K (-0.24 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.00 | 100 | 3,100 | 42,515 | 42.6 K to 42.5 K (-0.23 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.99 | 100 | 3,099 | 42,615 | 42.7 K to 42.6 K (-0.23 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.96 | 100 | 3,096 | 42,715 | 42.8 K to 42.7 K (-0.23 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.94 | 200 | 6,188 | 42,815 | 43 K to 42.8 K (-0.46 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.91 | 500 | 15,455 | 43,015 | 43.5 K to 43 K (-1.15 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.90 | 200 | 6,180 | 43,515 | 43.7 K to 43.5 K (-0.46 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.89 | 400 | 12,356 | 43,715 | 44.1 K to 43.7 K (-0.91 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.88 | 200 | 6,176 | 44,115 | 44.3 K to 44.1 K (-0.45 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.87 | 200 | 6,174 | 44,315 | 44.5 K to 44.3 K (-0.45 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.86 | 700 | 21,602 | 44,515 | 45.2 K to 44.5 K (-1.55 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.85 | 2,600 | 80,210 | 45,215 | 47.8 K to 45.2 K (-5.44 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.84 | 500 | 15,420 | 47,815 | 48.3 K to 47.8 K (-1.03 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.83 | 900 | 27,747 | 48,315 | 49.2 K to 48.3 K (-1.83 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.82 | 100 | 3,082 | 49,215 | 49.3 K to 49.2 K (-0.20 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | M | 2.60 | 29,200 | 75,920 | 28,777 | |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.81 | 100 | 3,081 | 49,315 | 49.4 K to 49.3 K (-0.20 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.80 | 400 | 12,320 | 49,415 | 49.8 K to 49.4 K (-0.80 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.79 | 400 | 12,316 | 49,815 | 50.2 K to 49.8 K (-0.80 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.78 | 600 | 18,468 | 50,215 | 50.8 K to 50.2 K (-1.18 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.77 | 400 | 12,308 | 50,815 | 51.2 K to 50.8 K (-0.78 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.75 | 340 | 10,455 | 51,215 | 51.6 K to 51.2 K (-0.66 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.74 | 60 | 1,844 | 51,555 | 51.6 K to 51.6 K (-0.12 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.73 | 200 | 6,146 | 51,615 | 51.8 K to 51.6 K (-0.39 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.73 | 200 | 6,145 | 51,815 | 52 K to 51.8 K (-0.38 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.72 | 400 | 12,288 | 52,015 | 52.4 K to 52 K (-0.76 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.71 | 100 | 3,071 | 52,415 | 52.5 K to 52.4 K (-0.19 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.70 | 200 | 6,140 | 52,515 | 52.7 K to 52.5 K (-0.38 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.69 | 400 | 12,276 | 52,715 | 53.1 K to 52.7 K (-0.75 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.68 | 100 | 3,068 | 53,115 | 53.2 K to 53.1 K (-0.19 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.66 | 300 | 9,198 | 53,215 | 53.5 K to 53.2 K (-0.56 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.65 | 400 | 12,260 | 53,515 | 53.9 K to 53.5 K (-0.74 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.62 | 300 | 9,186 | 53,915 | 54.2 K to 53.9 K (-0.55 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.61 | 500 | 15,305 | 54,215 | 54.7 K to 54.2 K (-0.91 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.60 | 500 | 15,300 | 54,715 | 55.2 K to 54.7 K (-0.91 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.60 | 100 | 3,060 | 55,215 | 55.3 K to 55.2 K (-0.18 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.59 | 700 | 21,413 | 55,315 | 56 K to 55.3 K (-1.25 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.58 | 300 | 9,174 | 56,015 | 56.3 K to 56 K (-0.53 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.57 | 800 | 24,456 | 56,315 | 57.1 K to 56.3 K (-1.40 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.56 | 300 | 9,168 | 57,115 | 57.4 K to 57.1 K (-0.52 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.55 | 300 | 9,165 | 57,415 | 57.7 K to 57.4 K (-0.52 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.54 | 500 | 15,270 | 57,715 | 58.2 K to 57.7 K (-0.86 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.52 | 300 | 9,156 | 58,215 | 58.5 K to 58.2 K (-0.51 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Buy | M | 2.60 | 29,200 | 75,920 | 58,515 | 29.3 K to 58.5 K (+99.61 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 5.85 | 7,000 | 40,950 | 21,500 | |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.84 | 100 | 3,184 | 12,400 | 12.5 K to 12.4 K (-0.80 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.69 | 400 | 12,676 | 12,500 | 12.9 K to 12.5 K (-3.10 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.68 | 100 | 3,168 | 12,900 | 13 K to 12.9 K (-0.77 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.68 | 700 | 22,176 | 13,000 | 13.7 K to 13 K (-5.11 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.67 | 1,000 | 31,670 | 13,700 | 14.7 K to 13.7 K (-6.80 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.67 | 100 | 3,167 | 14,700 | 14.8 K to 14.7 K (-0.68 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 21.67 | 200 | 4,333 | 14,800 | 15 K to 14.8 K (-1.33 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.66 | 900 | 28,494 | 15,000 | 15.9 K to 15 K (-5.66 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.66 | 200 | 6,331 | 15,900 | 16.1 K to 15.9 K (-1.24 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.65 | 200 | 6,330 | 16,100 | 16.3 K to 16.1 K (-1.23 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.63 | 100 | 3,163 | 16,300 | 16.4 K to 16.3 K (-0.61 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.61 | 100 | 3,161 | 16,400 | 16.5 K to 16.4 K (-0.61 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.60 | 400 | 12,640 | 16,500 | 16.9 K to 16.5 K (-2.37 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.59 | 300 | 9,477 | 16,900 | 17.2 K to 16.9 K (-1.74 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.59 | 100 | 3,159 | 17,200 | 17.3 K to 17.2 K (-0.58 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.58 | 500 | 15,790 | 17,300 | 17.8 K to 17.3 K (-2.81 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.58 | 200 | 6,316 | 17,800 | 18 K to 17.8 K (-1.11 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.58 | 300 | 9,473 | 18,000 | 18.3 K to 18 K (-1.64 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.89 | 100 | 3,089 | 18,300 | 18.4 K to 18.3 K (-0.54 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.88 | 100 | 3,088 | 18,400 | 18.5 K to 18.4 K (-0.54 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.87 | 100 | 3,087 | 18,500 | 18.6 K to 18.5 K (-0.54 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.86 | 600 | 18,516 | 18,600 | 19.2 K to 18.6 K (-3.12 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.85 | 100 | 3,085 | 19,200 | 19.3 K to 19.2 K (-0.52 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.50 | 100 | 3,050 | 19,300 | 19.4 K to 19.3 K (-0.52 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 5.85 | 7,000 | 40,950 | 19,400 | 12.4 K to 19.4 K (+56.45 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Option Exercise | M | 5.85 | 3,500 | 20,475 | 25,000 | |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.71 | 100 | 3,171 | 26,164 | 26.3 K to 26.2 K (-0.38 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.66 | 100 | 3,166 | 26,264 | 26.4 K to 26.3 K (-0.38 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.65 | 100 | 3,165 | 26,364 | 26.5 K to 26.4 K (-0.38 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.64 | 200 | 6,328 | 26,464 | 26.7 K to 26.5 K (-0.75 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.59 | 200 | 6,318 | 26,664 | 26.9 K to 26.7 K (-0.74 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.58 | 100 | 3,158 | 26,864 | 27 K to 26.9 K (-0.37 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.57 | 400 | 12,628 | 26,964 | 27.4 K to 27 K (-1.46 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.56 | 600 | 18,936 | 27,364 | 28 K to 27.4 K (-2.15 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.50 | 1,700 | 53,550 | 27,964 | 29.7 K to 28 K (-5.73 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Buy | M | 5.85 | 3,500 | 20,475 | 29,664 | 26.2 K to 29.7 K (+13.38 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | M | 2.60 | 800 | 2,080 | 57,977 | |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.50 | 300 | 9,450 | 29,315 | 29.6 K to 29.3 K (-1.01 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.52 | 200 | 6,304 | 29,615 | 29.8 K to 29.6 K (-0.67 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.54 | 200 | 6,308 | 29,815 | 30 K to 29.8 K (-0.67 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.58 | 100 | 3,158 | 30,015 | 30.1 K to 30 K (-0.33 %) |
| Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Buy | M | 2.60 | 800 | 2,080 | 30,115 | 29.3 K to 30.1 K (+2.73 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 29.84 | 500 | 14,920 | 29,315 | 29.8 K to 29.3 K (-1.68 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 29.85 | 100 | 2,985 | 29,815 | 29.9 K to 29.8 K (-0.33 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 29.86 | 300 | 8,958 | 29,915 | 30.2 K to 29.9 K (-0.99 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 29.88 | 100 | 2,988 | 30,215 | 30.3 K to 30.2 K (-0.33 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 29.89 | 100 | 2,989 | 30,315 | 30.4 K to 30.3 K (-0.33 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.12 | 100 | 3,012 | 30,415 | 30.5 K to 30.4 K (-0.33 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.20 | 100 | 3,020 | 30,515 | 30.6 K to 30.5 K (-0.33 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.21 | 100 | 3,021 | 30,615 | 30.7 K to 30.6 K (-0.33 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.31 | 100 | 3,031 | 30,715 | 30.8 K to 30.7 K (-0.32 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.32 | 100 | 3,032 | 30,815 | 30.9 K to 30.8 K (-0.32 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.33 | 100 | 3,033 | 30,915 | 31 K to 30.9 K (-0.32 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.38 | 400 | 12,152 | 31,015 | 31.4 K to 31 K (-1.27 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.51 | 100 | 3,051 | 31,415 | 31.5 K to 31.4 K (-0.32 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.56 | 100 | 3,056 | 31,515 | 31.6 K to 31.5 K (-0.32 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.60 | 100 | 3,060 | 31,615 | 31.7 K to 31.6 K (-0.32 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.61 | 200 | 6,122 | 31,715 | 31.9 K to 31.7 K (-0.63 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.64 | 100 | 3,064 | 31,915 | 32 K to 31.9 K (-0.31 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.65 | 100 | 3,065 | 32,015 | 32.1 K to 32 K (-0.31 %) |
| Jun 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 30.78 | 300 | 9,234 | 32,115 | 32.4 K to 32.1 K (-0.93 %) |